UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 115

Sortiert nach

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone

The New England journal of medicine, 2016-05, Vol.374 (19), p.1822-1830

2016

Volltextzugriff (PDF)

Combining multiple lines of evidence to elucidate the origin and introduction pathway of bitou bush (Chrysanthemoides monilifera subsp. rotundata) in Australia

Biological invasions, 2023-06, Vol.25 (6), p.1881-1905

2023

Volltextzugriff (PDF)

Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations

Respiratory medicine, 2008-08, Vol.102 (8), p.1099-1108

2008

Volltextzugriff (PDF)

β2-Receptor Polymorphisms in Patients Receiving Salmeterol with or without Fluticasone Propionate

American journal of respiratory and critical care medicine, 2010-04, Vol.181 (7), p.676-687

2010

Volltextzugriff (PDF)

A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD

BMC pulmonary medicine, 2020-05, Vol.20 (1), p.119-10, Article 119

2020

Volltextzugriff (PDF)

Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes

Chronic obstructive pulmonary disease, 2009, Vol.6 (5), p.320-329

2009

Volltextzugriff (PDF)

Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD

The European respiratory journal, 2013-08, Vol.42 (2), p.539-541

2013

Volltextzugriff (PDF)

Body Mass Index and Response to Asthma Therapy: Fluticasone Propionate/Salmeterol versus Montelukast

The Journal of asthma, 2010-02, Vol.47 (1), p.76-82

2010

Volltextzugriff (PDF)

Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD

Respiratory medicine, 2011-09, Vol.105 (9), p.1322-1330

2011

Volltextzugriff (PDF)

Prevalence of COPD among symptomatic patients in a primary care setting

Current medical research and opinion, 2009-11, Vol.25 (11), p.2671-2677

2009

Volltextzugriff (PDF)

Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD

Chest, 2001-06, Vol.119 (6), p.1661-1670

2001

Volltextzugriff (PDF)

Effect of increased body mass index on asthma risk, impairment and response to asthma controller therapy in African Americans

Current medical research and opinion, 2010-07, Vol.26 (7), p.1629-1635

2010

Volltextzugriff (PDF)

Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast

Journal of allergy and clinical immunology, 2000-12, Vol.106 (6), p.1088-1095

2000

Volltextzugriff (PDF)

Comparative effect of body mass index on response to asthma controller therapy

Allergy and asthma proceedings, 2010-01, Vol.31 (1), p.20

2010

Volltextzugriff (PDF)

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations

Journal of allergy and clinical immunology, 2001-05, Vol.107 (5), p.783-789

2001

Volltextzugriff (PDF)

Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy

Chest, 2001-08, Vol.120 (2), p.423-430

2001

Volltextzugriff (PDF)

Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting β2-agonists

The Journal of pediatrics, 2006-04, Vol.148 (4), p.517-521

2006

Volltextzugriff (PDF)

Meeting the obligation to balance bioethics and clinical trial design in asthma

American journal of respiratory and critical care medicine, 2010-04, Vol.181 (7), p.648-650

2010

Volltextzugriff (PDF)

Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real‐world cohorts

Journal of viral hepatitis, 2022-12, Vol.29 (12), p.1050-1061

2022

Volltextzugriff (PDF)

Lack of Subsensitivity to Albuterol After Treatment with Salmeterol in Patients with Asthma

American journal of respiratory and critical care medicine, 1999-05, Vol.159 (5), p.1556-1561

1999

Volltextzugriff (PDF)

Effect of Long-term Salmeterol Therapy Compared With As-Needed Albuterol Use on Airway Hyperresponsiveness

Chest, 1999-09, Vol.116 (3), p.595-602

1999

Volltextzugriff (PDF)

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk

International journal of chronic obstructive pulmonary disease, 2016-01, Vol.11 (default), p.1-12

2016

Volltextzugriff (PDF)

Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts

Advances in therapy, 2021-06, Vol.38 (6), p.3409-3426

2021

Volltextzugriff (PDF)

Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation

Respiratory research, 2014-09, Vol.15 (1), p.105-105, Article 105

2014

Volltextzugriff (PDF)

Disease severity and symptoms among patients receiving monotherapy for COPD

Primary care respiratory journal, 2011-03, Vol.20 (1), p.46-53

2011

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(112)
Mit Volltextzugriff
(111)

Publikationsform

Artikel
(113)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(115)
Japanisch
(12)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Serious Asthma Events with Fluticasone plus Salmeterol versus Fluticasone Alone

Combining multiple lines of evidence to elucidate the origin and introduction pathway of bitou bush (Chrysanthemoides monilifera subsp. rotundata) in Australia

Effect of fluticasone propionate/salmeterol (250/50 μg) or salmeterol (50 μg) on COPD exacerbations

β2-Receptor Polymorphisms in Patients Receiving Salmeterol with or without Fluticasone Propionate

A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPD

Effect of Fluticasone Propionate/Salmeterol (250/50) on COPD Exacerbations and Impact on Patient Outcomes

Effect of fluticasone propionate/salmeterol plus tiotropium versus tiotropium on walking endurance in COPD

Body Mass Index and Response to Asthma Therapy: Fluticasone Propionate/Salmeterol versus Montelukast

Effect of fluticasone propionate/salmeterol on arterial stiffness in patients with COPD

Prevalence of COPD among symptomatic patients in a primary care setting

Salmeterol Plus Theophylline Combination Therapy in the Treatment of COPD

Effect of increased body mass index on asthma risk, impairment and response to asthma controller therapy in African Americans

Fluticasone propionate/salmeterol combination provides more effective asthma control than low-dose inhaled corticosteroid plus montelukast

Comparative effect of body mass index on response to asthma controller therapy

Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations

Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy

Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting β2-agonists

Meeting the obligation to balance bioethics and clinical trial design in asthma

Safety analysis of glecaprevir/pibrentasvir in patients with markers of advanced liver disease in clinical and real‐world cohorts

Lack of Subsensitivity to Albuterol After Treatment with Salmeterol in Patients with Asthma

Effect of Long-term Salmeterol Therapy Compared With As-Needed Albuterol Use on Airway Hyperresponsiveness

Efficacy and safety of fluticasone furoate/vilanterol or tiotropium in subjects with COPD at cardiovascular risk

Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts

Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation

Disease severity and symptoms among patients receiving monotherapy for COPD

Suchergebnisse filtern